The first genetically confirmed cohort of Facioscapulohumeral Muscular Dystrophy from Northern India

被引:1
|
作者
Vishnu, Venugopalan Y. [1 ]
Lemmers, Richard J. L. F. [2 ]
Reyaz, Alisha [1 ]
Mishra, Rinkle [1 ]
Ahmad, Tanveer [1 ]
van der Vliet, Patrick J. [2 ]
Kretkiewicz, Marcelina M. [2 ]
Macken, William L. [3 ,4 ]
Efthymiou, Stephanie [5 ,6 ]
Dominik, Natalia [5 ,6 ]
Morrow, Jasper M. [5 ,6 ]
Bhatia, Rohit [1 ]
Wilson, Lindsay A. [5 ,6 ]
Houlden, Henry [5 ,6 ]
Hanna, Michael G. [3 ,4 ]
Bugiardini, Enrico [5 ,6 ]
van der Maarel, Silvere M. [2 ]
Srivastava, M. V. Padma [1 ]
机构
[1] All India Inst Med Sci AIIMS, Dept Neurol, New Delhi, Delhi, India
[2] Leiden Univ Med Ctr LUMC, Dept Human Genet, Leiden, Netherlands
[3] UCL, Queen Sq Inst Neurol, Dept Neuromuscular Dis, London, England
[4] Natl Hosp Neurol & Neurosurg, Queen Sq Ctr Neuromuscular Dis, NHS Highly Specialised Serv Rare Mitochondrial Dis, London, England
[5] Queen Sq UCL Inst Neurol, Dept Neuromuscular Dis, London, England
[6] Natl Hosp Neurol & Neurosurg, London, England
基金
英国医学研究理事会;
关键词
ACCURATE DIAGNOSIS; COPY NUMBER; D4Z4; PENETRANCE; MODIFIER; VARIANT; REPEAT; SMCHD1;
D O I
10.1038/s41431-024-01577-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Facioscapulohumeral muscular dystrophy (FSHD) is the third most common form of hereditary myopathy. Sixty per cent of the world's population lives in Asia, so a significant percentage of the world's FSHD participants is expected to live there. To date, most FSHD studies have involved individuals of European descent, yet small-scale studies of East-Asian populations suggest that the likelihood of developing FSHD may vary. Here, we present the first genetically confirmed FSHD cohort of Indian ancestry, which suggests a pathogenic FSHD1 allele size distribution intermediate between European and North-East Asian populations and more asymptomatic carriers of 4 unit and 5 unit FSHD1 alleles than observed in European populations. Our data provides important evidence of differences relevant to clinical diagnostics and underscores the need for global FSHD participation in research and trial-ready Indian FSHD cohorts.
引用
收藏
页码:1053 / 1064
页数:12
相关论文
共 50 条
  • [1] Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy
    Laforêt, P
    de Toma, C
    Eymard, B
    Becane, HM
    Jeanpierre, M
    Fardeau, M
    Duboc, D
    NEUROLOGY, 1998, 51 (05) : 1454 - 1456
  • [2] A cross sectional study of genetically confirmed cohort of facioscapulohumeral muscular dystrophy (FSHD) in the Indian population
    Vishnu, V.
    Lemmers, R.
    Bugiardini, E.
    Reyaz, A.
    Efthymiou, S.
    van der Maarel, S.
    Bhatia, R.
    Pitceathly, R.
    Srivastava, P.
    Hanna, M.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S105 - S105
  • [3] Patient-Reported Disease Burden and Progression in Genetically Confirmed Participants in a National Facioscapulohumeral Muscular Dystrophy Registry
    Statland, Jeffrey
    Martens, William
    Tawil, Alrabi
    NEUROLOGY, 2012, 78
  • [4] Baseline characteristics of the CINRG infantile facioscapulohumeral muscular dystrophy cohort
    Duong, T.
    Eagle, M.
    Feng, J.
    Mah, J.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S215 - S215
  • [5] Facial paresis as the first sign in atypical facioscapulohumeral muscular dystrophy
    Wamkpah, Nneoma S.
    Chi, John J.
    OTOLARYNGOLOGY CASE REPORTS, 2022, 25
  • [6] Facial paresis as the first sign in atypical facioscapulohumeral muscular dystrophy
    Wamkpah, Nneoma S.
    Chi, John J.
    OTOLARYNGOLOGY CASE REPORTS, 2022, 25
  • [7] Baseline characteristics of the CINRG infantile facioscapulohumeral muscular dystrophy (FSHD) cohort
    Mah, J. K.
    Chen, Y. W.
    Duong, T.
    Cnaan, A.
    Sund, Z.
    Morgenroth, L. P.
    McDonald, C.
    Tulinius, M.
    Sparks, S.
    Webster, R.
    Connolly, A.
    Karachunski, P.
    Clemens, P. R.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 798 - 798
  • [8] Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort
    Kelly, Cecilia R.
    Saw, Jacqui-Lyn
    Thapa, Prabin
    Mandrekar, Jay
    Naddaf, Elie
    MUSCLE & NERVE, 2022, 65 (04) : 415 - 421
  • [9] Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study
    Elvira Ragozzino
    Sara Bortolani
    Lorena Di Pietro
    Andrea Papait
    Ornella Parolini
    Mauro Monforte
    Giorgio Tasca
    Enzo Ricci
    Acta Neuropathologica Communications, 11
  • [10] Genetically Confirmed Patients with Merosin-deficient Congenital Muscular Dystrophy in China
    Yuan, J.
    Takashima, H.
    Higuchi, I.
    Arimura, K.
    Li, N.
    Zhao, Z.
    Shen, H.
    Hu, J.
    NEUROPEDIATRICS, 2008, 39 (05) : 264 - 267